NasdaqGS - Delayed Quote USD

IO Biotech, Inc. (IOBT)

1.3500
-0.1500
(-10.00%)
At close: June 13 at 4:00:02 PM EDT
1.3600
+0.01
+(0.74%)
After hours: June 13 at 7:21:58 PM EDT

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue --
Earnings -20.85M

Q2'24

Q3'24

Q4'24

Q1'25

-20M
-10M
0
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

6.00
9.50 Average
1.3500 Current
14.00 High

Earnings Estimate

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
No. of Analysts 1112
Avg. Estimate -0.3-0.25-1.14-0.99
Low Estimate -0.3-0.25-1.14-0.99
High Estimate -0.3-0.25-1.14-0.98
Year Ago EPS -0.28-0.34-1.35-1.14

Revenue Estimate

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
No. of Analysts 4445
Avg. Estimate ------19.27M
Low Estimate ------4.7M
High Estimate ------42.26M
Year Ago Sales --------
Sales Growth (year/est) 0.00%0.00%0.00%0.00%

Earnings History

Currency in USD 6/30/2024 9/30/2024 12/31/2024 3/31/2025
EPS Est. -0.33-0.35-0.38-0.23
EPS Actual -0.28-0.34-0.46-0.32
Difference 0.050.01-0.07-0.09
Surprise % 14.39%2.80%-18.70%-37.61%

EPS Trend

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
Current Estimate -0.3-0.25-1.14-0.99
7 Days Ago -0.24-0.29-1.17-1.25
30 Days Ago -0.24-0.29-1.17-1.25
60 Days Ago -0.24-0.29-1.17-1.25
90 Days Ago 00-1.29-1.51

EPS Revisions

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days ----11
Up Last 30 Days ----11
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
IOBT -6.19%26.51%15.58%13.60%
S&P 500 13.13%2.43%7.54%14.06%

Upgrades & Downgrades

Reiterates HC Wainwright & Co.: Buy to Buy 4/1/2025
Reiterates HC Wainwright & Co.: Buy to Buy 3/5/2025
Reiterates HC Wainwright & Co.: Buy to Buy 11/12/2024
Reiterates HC Wainwright & Co.: Buy to Buy 11/6/2024
Maintains Morgan Stanley: Overweight to Overweight 9/16/2024
Reiterates HC Wainwright & Co.: Buy to Buy 9/16/2024

Related Tickers